Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphatic Diseases × Bendamustine Hydrochloride × Clear all

Phase

Status

Active not recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 12 Lymphoma, Non-Hodgkin 10 Lymphoma, Follicular 7 Lymphoma 6 Multiple Myeloma 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, B-Cell, Marginal Zone 4 Leukemia 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell 3 Waldenstrom Macroglobulinemia 2 Leukemia, Myeloid, Acute 2 Burkitt Lymphoma 2 Sezary Syndrome 1 Pancreatic Neoplasms 1 Neurologic Manifestations 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphatic Diseases 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphoid 1 Leukemia, Hairy Cell 1 Intraocular Lymphoma 1 Hematologic Neoplasms 1 Brain Neoplasms 1

Interventions

Rituximab 3 Cyclophosphamide 3 cobomarsen 2 Vincristine 2 Prednisone 2 Ifosfamide 2 Etoposide 2 Doxorubicin 2 Carboplatin 2 Brentuximab Vedotin 2 ponatinib 1 pomalidomide 1 fludarabine 1 dacetuzumab 1 Vorinostat 1 Imatinib Mesylate 1 Everolimus 1 DTRMWXHS-12 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02499627 2021-05-27

FIL-BBV

Fondazione Italiana Linfomi - ETS

Phase 2 Terminated

Lymphatic Diseases, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡